Labcorp adds new COVID-19 antigen test to repertoire

By LabPulse.com staff writers

February 18, 2021 -- Labcorp has added a new high sensitivity antigen test for screening for active COVID-19 disease to its testing offerings. The nasal swab test was developed by DiaSorin.

The test is called Liaison SARS-CoV-2, and it was cleared by the U.S. Food and Drug Administration (FDA) in October of 2020. The test is available through a doctor's order, Labcorp said. Results are available within 24 to 48 hours.


Copyright © 2021 LabPulse.com
 

To read this and get access to all of the exclusive content on LabPulse.com, create a free account or sign in now.

Member Sign In:
MemberID or email address:  
Do you have a LabPulse.com password?
No, I want a free membership.
Yes, I have a password:  
Forgot your password?